209 related articles for article (PubMed ID: 11585386)
1. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
Oshima Y; Puri RK
Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin 13 in classical Hodgkin lymphoma.
Skinnider BF; Kapp U; Mak TW
Leuk Lymphoma; 2002 Jun; 43(6):1203-10. PubMed ID: 12152987
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
5. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.
Murata T; Obiri NI; Debinski W; Puri RK
Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
Joshi BH; Leland P; Puri RK
Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
[TBL] [Abstract][Full Text] [Related]
7. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells.
Gruss HJ; Brach MA; Drexler HG; Bross KJ; Herrmann F
Cancer Res; 1992 Feb; 52(4):1026-31. PubMed ID: 1737332
[TBL] [Abstract][Full Text] [Related]
9. Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues.
Hsu PL; Lin YC; Hsu SM
Int J Hematol; 1991 Aug; 54(4):315-26. PubMed ID: 1838015
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
11. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
Cattaruzza L; Gloghini A; Olivo K; Di Francia R; Lorenzon D; De Filippi R; Carbone A; Colombatti A; Pinto A; Aldinucci D
Int J Cancer; 2009 Sep; 125(5):1092-101. PubMed ID: 19391137
[TBL] [Abstract][Full Text] [Related]
12. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
15. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
16. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor.
He YW; Malek TR
J Immunol; 1995 Jul; 155(1):9-12. PubMed ID: 7602126
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis.
Ohshima K; Akaiwa M; Umeshita R; Suzumiya J; Izuhara K; Kikuchi M
Histopathology; 2001 Apr; 38(4):368-75. PubMed ID: 11318902
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236.
Andersson E; Schain F; Sjöberg J; Björkholm M; Claesson HE
Exp Hematol; 2010 Feb; 38(2):116-23. PubMed ID: 19931589
[TBL] [Abstract][Full Text] [Related]
20. Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236.
Re D; Benenson E; Beyer M; Gresch O; Draube A; Diehl V; Wolf J
Am J Hematol; 2001 May; 67(1):6-9. PubMed ID: 11279650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]